Nitric oxide vs insulin secretion, action and clearance

Diabetologia

Volumn 57, Issue 1, 2014, Pages 257-258

  Kruszelnicka, Olga ^a  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Asymmetric dimethylarginine; Insulin clearance; Insulin resistance; Insulin secretion; Nitric oxide

Indexed keywords

INSULIN; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

INSULIN CLEARANCE; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESISTANCE; LETTER; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

ENZYME INHIBITORS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE;

EID: 84890936040     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3082-y     Document Type: Letter

References (12)

1. Natali A, Ribeiro R, Baldi S et al (2013) Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia 56:1183-1191
2. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD (2000) Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49:684-687
3. Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978-1986
4. Perticone F, Maio R, Sciacqua A et al (2008) Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes 57:167-171
5. Mittermayer F, Kautzky-Willer A, Winzer C et al (2007) Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus. J Intern Med 261:392-398
6. Surdacki A, Kruszelnicka O, Rakowski T, Jawińska-Kozuba A, Dubiel JS (2013) Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study. Cardiovasc Diabetol 12:64
7. Reaven GM (2013) What do we learn from measurements of HOMA-IR? Diabetologia 56:1867-1868
8. Cordes CM, Bennett RG, Siford GL, Hamel FG (2009) Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem Pharmacol 77:1064-1073
9. Wiseman DA, Thurmond DC (2012) The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act. Curr Diabetes Rev 8:303-315
10. Forrester MT, Seth D, Hausladen A et al (2009) Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation. J Biol Chem 284:36160-36166
11. Shaked M, Ketzinel-Gilad M, Ariav Y, Cerasi E, Kaiser N, Leibowitz G (2009) Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Diabetologia 52:636-644
12. Wang H, Wang AX, Aylor K, Barrett EJ (2013) Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes. doi: 10.2337/db13-0627